BridgeBio Oncology Therapeutics, Inc. (BBOT)
NGM · Common · CUSIP 107924102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BBOT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
107924102
Business: BridgeBio Oncology Therapeutics, Inc. aims to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.

Company Contact

CEO
Eli Wallace
CFO
Uneek Mehra
Headquarters
256 E. Grand Avenue, Suite 104, South San Francisco, CA
Phone
650-405-4770
Investor Relations
Chinmay Shukla · ir@bridgebio.com
SEC EDGAR Filings
View filings »